Engineered Liposomes Protect Immortalized Immune Cells from Cytolysins Secreted by Group A and Group G Streptococci

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 1; p. 166
• Main Authors: Besançon, Hervé, Larpin, Yu, Babiychuk, Viktoria S, Köffel, René, Babiychuk, Eduard B
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 05.01.2022; MDPI
• Subjects: Antibiotic resistance; Antibiotics; Apoptosis; Bacteremia; Bacteria; bacterial infection; Cell Death - drug effects; Cell Line; Cell Line, Transformed; Cell membranes; Cholesterol; Cholesterol - metabolism; Cytolysins; Cytotoxins - toxicity; Drug dosages; Drug resistance; Exotoxins; Humans; Leukocytes - drug effects; Leukocytes - metabolism; Lipids; liposome; Liposomes; Liposomes - chemistry; Mass spectrometry; Mimicry; nanotrap; Neutralization Tests; Pathogens; Peptides; Phospholipids; Pneumonia; Scientific imaging; Streptococcus; Streptococcus - metabolism; Streptococcus infections; Streptococcus pyogenes - metabolism; toxin; Toxins; Virulence; Virulence factors; United States > US; Switzerland; Germany; Streptococcus; nanotrap; toxin; antibiotic resistance; immune cells; bacterial infection; liposome; antivirulence
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11010166

The increasing antibiotic resistance of bacterial pathogens fosters the development of alternative, non-antibiotic treatments. Antivirulence therapy, which is neither bacteriostatic nor bactericidal, acts by depriving bacterial pathogens of their virulence factors. To establish a successful infection, many bacterial pathogens secrete exotoxins/cytolysins that perforate the host cell plasma membrane. Recently developed liposomal nanotraps, mimicking the outer layer of the targeted cell membranes, serve as decoys for exotoxins, thus diverting them from attacking host cells. In this study, we develop a liposomal nanotrap formulation that is capable of protecting immortalized immune cells from the whole palette of cytolysins secreted by and subsp. -important human pathogens that can cause life-threatening bacteremia. We show that the mixture of cholesterol-containing liposomes with liposomes composed exclusively of phospholipids is protective against the combined action of all streptococcal exotoxins. Our findings pave the way for further development of liposomal antivirulence therapy in order to provide more efficient treatment of bacterial infections, including those caused by antibiotic resistant pathogens.